What is the price-to-earnings ratio of Europlasma?
The price-earnings ratio of Europlasma is currently -1.63.
Europlasma P/E 2024
Europlasma P/E
-1.63
Ticker
ALEUP.PA
ISIN
FR0013514114
WKN
A2P7LH
As of Nov 19, 2024, Europlasma's P/E ratio was -1.63, a -93.12% change from the -23.69 P/E ratio recorded in the previous year.
The Europlasma P/E history
Europlasma Aktienanalyse
What does Europlasma do?
Europlasma SA is an internationally operating company based in France, specializing in the development, manufacturing, and marketing of advanced plasma technologies for surface treatment and environmentally friendly waste treatment. Since its founding in 1992, the company has experienced strong growth and a strong presence in international markets. The business model of Europlasma SA is based on the development of innovative technologies and providing solutions for demanding industrial applications, particularly in the areas of energy generation, waste management, coatings, and material treatment. The company works closely with its customers to develop customized solutions that meet their specific requirements. Europlasma SA offers a wide range of products and services based on its core competencies. The main divisions include: - Plasma systems for energy generation: Europlasma SA has developed a range of plasma systems that can be used to generate renewable energy from biomass, waste, or other organic materials. These systems convert the input materials into syngas, which can be used as fuel for the generation of electricity and heat. - Plasma systems for waste treatment: Europlasma SA has also developed plasma systems that can be used for environmentally friendly treatment of toxic and hazardous waste. These systems destroy organic compounds and reduce the volume of waste, resulting in a significant reduction in disposal costs. - Plasma systems for surface treatment: Europlasma SA has developed plasma systems that can be used for coating and processing surfaces. These systems can process and coat a variety of materials such as plastics, metals, and ceramics to improve their properties or give them specific functions. - Plasma systems for sterilization: Europlasma SA has also developed plasma systems that can be used for sterilizing medical devices and packaging. These systems can reliably remove germs, viruses, and other unwanted contaminants without the use of harmful chemicals. In addition to its core competencies, Europlasma SA also offers a wide range of services to help its customers optimize the use of their systems. For example, the company provides training, technical support, and maintenance services to ensure that its customers' systems are always up-to-date and functioning optimally. In recent years, Europlasma SA has shown strong growth dynamics and strengthened its position in international markets. The company is headquartered in France and has subsidiaries and branches around the world, including the USA, China, India, and South Africa. Overall, Europlasma SA is a company that specializes in the development and provision of innovative plasma technologies that can be used in a variety of industrial applications. The company has shown strong growth in recent years and strengthened its position in international markets. With its wide range of products and services, the company presents a forward-looking technological solution that makes a significant contribution to a better environment and energy efficiency. Europlasma ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Europlasma's P/E Ratio
The Price to Earnings (P/E) Ratio of Europlasma is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Europlasma's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Europlasma is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Europlasma’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Europlasma stock
How has the price-earnings ratio of Europlasma changed compared to last year?
The price-to-earnings ratio of Europlasma has increased by -93.12% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Europlasma high compared to other companies?
Yes, the price-to-earnings ratio of Europlasma is high compared to other companies.
How does an increase in the price-earnings ratio of Europlasma affect the company?
An increase in the price-earnings ratio of Europlasma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Europlasma affect the company?
A decrease in the price-earnings ratio of Europlasma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Europlasma?
Some factors that influence the price-earnings ratio of Europlasma are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Europlasma pay?
Over the past 12 months, Europlasma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Europlasma is expected to pay a dividend of 0 EUR.
What is the dividend yield of Europlasma?
The current dividend yield of Europlasma is .
When does Europlasma pay dividends?
Europlasma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Europlasma?
Europlasma paid dividends every year for the past 0 years.
What is the dividend of Europlasma?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Europlasma located?
Europlasma is assigned to the 'Industry' sector.
Wann musste ich die Aktien von Europlasma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Europlasma from 11/19/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.
When did Europlasma pay the last dividend?
The last dividend was paid out on 11/19/2024.
What was the dividend of Europlasma in the year 2023?
In the year 2023, Europlasma distributed 0 EUR as dividends.
In which currency does Europlasma pay out the dividend?
The dividends of Europlasma are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Europlasma
Our stock analysis for Europlasma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Europlasma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
